CD203 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD203 monoclonal antibodies for advanced research in cellular biology. CD203 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD203, also known as the ecto-nucleotide triphosphate diphosphohydrolase-1 (NTPDase-1), plays a crucial role in purinergic signaling by hydrolyzing extracellular ATP, which is essential for regulating immune responses and cell proliferation. CD203 expression is frequently observed during mast cell activation and has significant implications in various pathological conditions, including allergies and inflammation. Understanding CD203 function is vital for developing therapeutic strategies targeting immune-related diseases. CD203 monoclonal antibodies enable detailed investigation of cellular mechanisms and pathways involved in immune system regulation. CD203 monoclonal antibodies support research focusing on ATP metabolism and its impact on cellular communication. CD203 monoclonal antibodies facilitate exploration of potential therapeutic targets in inflammatory disorders. Santa Cruz Biotechnology monoclonal antibodies continue to advance scientific understanding of immune system regulation and disease mechanisms.